These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 22910581)
1. Genomic characterization of two deletions in the LDLR gene in Tunisian patients with familial hypercholesterolemia. Jelassi A; Slimani A; Rabès JP; Jguirim I; Abifadel M; Boileau C; Najah M; M'rabet S; Mzid J; Slimane MN; Varret M Clin Chim Acta; 2012 Dec; 414():146-51. PubMed ID: 22910581 [TBL] [Abstract][Full Text] [Related]
2. Effect of mutations in LDLR and PCSK9 genes on phenotypic variability in Tunisian familial hypercholesterolemia patients. Slimani A; Jelassi A; Jguirim I; Najah M; Rebhi L; Omezzine A; Maatouk F; Hamda KB; Kacem M; Rabès JP; Abifadel M; Boileau C; Rouis M; Slimane MN; Varret M Atherosclerosis; 2012 May; 222(1):158-66. PubMed ID: 22417841 [TBL] [Abstract][Full Text] [Related]
3. Effect of a splice site mutation in LDLR gene and two variations in PCSK9 gene in Tunisian families with familial hypercholesterolaemia. Jelassi A; Slimani A; Jguirim I; Najah M; Maatouk F; Varret M; Slimane MN Ann Clin Biochem; 2011 Jan; 48(Pt 1):83-6. PubMed ID: 21115573 [TBL] [Abstract][Full Text] [Related]
4. Identification and functional characterization of LDLR mutations in familial hypercholesterolemia patients from Southern Italy. Romano M; Di Taranto MD; D'Agostino MN; Marotta G; Gentile M; Abate G; Mirabelli P; Di Noto R; Del Vecchio L; Rubba P; Fortunato G Atherosclerosis; 2010 Jun; 210(2):493-6. PubMed ID: 20045108 [TBL] [Abstract][Full Text] [Related]
5. The genetic spectrum of familial hypercholesterolemia in south-eastern Poland. Sharifi M; Walus-Miarka M; Idzior-Waluś B; Malecki MT; Sanak M; Whittall R; Li KW; Futema M; Humphries SE Metabolism; 2016 Mar; 65(3):48-53. PubMed ID: 26892515 [TBL] [Abstract][Full Text] [Related]
6. The contribution of PCSK9 levels to the phenotypic severity of familial hypercholesterolemia is independent of LDL receptor genotype. Drouin-Chartier JP; Tremblay AJ; Hogue JC; Ooi TC; Lamarche B; Couture P Metabolism; 2015 Nov; 64(11):1541-7. PubMed ID: 26371983 [TBL] [Abstract][Full Text] [Related]
7. Identification and characterization of new gain-of-function mutations in the PCSK9 gene responsible for autosomal dominant hypercholesterolemia. Abifadel M; Guerin M; Benjannet S; Rabès JP; Le Goff W; Julia Z; Hamelin J; Carreau V; Varret M; Bruckert E; Tosolini L; Meilhac O; Couvert P; Bonnefont-Rousselot D; Chapman J; Carrié A; Michel JB; Prat A; Seidah NG; Boileau C Atherosclerosis; 2012 Aug; 223(2):394-400. PubMed ID: 22683120 [TBL] [Abstract][Full Text] [Related]
12. The molecular basis of familial hypercholesterolemia in Lebanon: spectrum of LDLR mutations and role of PCSK9 as a modifier gene. Abifadel M; Rabès JP; Jambart S; Halaby G; Gannagé-Yared MH; Sarkis A; Beaino G; Varret M; Salem N; Corbani S; Aydénian H; Junien C; Munnich A; Boileau C Hum Mutat; 2009 Jul; 30(7):E682-91. PubMed ID: 19319977 [TBL] [Abstract][Full Text] [Related]
13. Detection of mutations and large rearrangements of the low-density lipoprotein receptor gene in Taiwanese patients with familial hypercholesterolemia. Chiou KR; Charng MJ Am J Cardiol; 2010 Jun; 105(12):1752-8. PubMed ID: 20538126 [TBL] [Abstract][Full Text] [Related]